No Data
No Data
Press Release: Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
Express News | Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $15
Express News | Eton Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $15 From $11
Eton Pharmaceuticals Has Acquired The Us Rights To Amglidia (Glyburide Oral Suspension, Known As Glibenclamide In Europe) For Neonatal Diabetes Mellitus From AMMTeK, Potential US Marketing Application Submission Expected In 2026
Express News | Eton Pharmaceuticals Inc - Plans FDA Meeting in Q1 2025, Nda Submission in 2026
Unlock the Full List